GCM Grosvenor Inc. (GCMG) is a Chicago-based alternative asset manager whose Class A shares trade on the Nasdaq. The firm builds customized and multi-client portfolios across private equity, infrastructure, real estate, credit, and absolute return strategies. With the stock recently changing hands near $13.37, the question facing investors is whether it can advance to the $15 level — a target that sits roughly 12% above the current price.
Four firms currently publish numeric 12-month price targets for GCM Grosvenor, while a fifth — William Blair — rates the shares Buy without attaching a figure. The four targets are J.P. Morgan at $13 (Hold), Piper Sandler at $15 (Overweight), TD Cowen at $16 (Buy), and Oppenheimer at $17 (Outperform). Averaging these values produces a mean of roughly $15.25, which rounds to the $15 central target used here. The range runs from $13 to $17.
The dispersion matters. J.P. Morgan holds a cautious stance, viewing the shares as fairly valued near current levels. At the opposite end, Oppenheimer and TD Cowen emphasize durable fee-revenue momentum and asset growth. Notably, even the bulls trimmed expectations in October 2026: Oppenheimer lowered its target from $18 to $17, and Piper Sandler reduced its target from $16 to $15 while both retained Buy-equivalent ratings. That pattern suggests constructive, but more measured, conviction than earlier in the year.
With shares near $13.37 and the central target at $15, the required move is about 12% — a modest advance that would still leave the stock roughly in line with its 52-week high near $14.87 and below the most optimistic analyst forecast. The path to $15 would likely depend on continued fee-related revenue growth, stable or rising AUM, and a firming in valuation rather than any single catalyst. The shares have been volatile, trading in a wide band between $9.30 and $14.87 over the past year.
GCM Grosvenor reported roughly $97 billion in AUM as of mid-2026, and fee-related revenue — the core recurring driver that excludes volatile performance fees — grew about 21% year over year in the second quarter. The firm raised approximately $1.2 billion for a first credit secondaries fund and has expanded its wealth-management distribution, including a September 2026 partnership with Hyperion Realty Capital. A quarterly dividend of $0.12 per share (a yield near 3.6%) provides income support. Consensus estimates project low-double-digit revenue growth and stronger earnings expansion in the coming year, which underpins the more optimistic price forecasts.
The primary obstacles are tied to the nature of alternative-asset economics. Performance fees and carried interest are inherently lumpy and difficult to time, and one-off "catch-up" fees can obscure underlying trends. The firm also carries meaningful balance-sheet leverage, which raises sensitivity to credit conditions and interest-rate moves. Competition in alternative asset management is intense, and the October target reductions from Oppenheimer and Piper Sandler signal that even supportive analysts see less near-term upside than before. A slowdown in fundraising or fee-paying AUM conversion would directly pressure the stock forecast.
The 52-week high near $14.87 represents the clearest resistance level — and it sits just below the $15 central target, meaning any advance toward that objective would first have to clear prior peaks. On the downside, the $12.50-to-$13 zone, which includes J.P. Morgan's target and recent consolidation, has acted as a support area. The $9.30 52-week low is a deeper reference point. The stock's wide annual range underscores elevated volatility relative to many larger financial names.
Analyst price targets generally reflect a research horizon of about 12 months, though individual assumptions vary and no single target is a guarantee. Investors should watch quarterly results — particularly fee-related revenue, AUM and net flows, and the conversion of contracted but not-yet-fee-paying assets — along with analyst target revisions, Federal Reserve interest-rate policy, and developments in credit and wealth-channel fundraising. Because performance fees are lumpy, focusing on recurring fee trends offers a clearer read on the underlying business than headline earnings alone.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor positions, and spot shifting trends more efficiently than manual screening. For investors tracking GCM Grosvenor's price forecast, it offers an additional, data-driven lens on short-term momentum alongside longer-horizon analyst targets.
The $15 central target is a calculated average of four current analyst price targets, not a published consensus or a prediction, and it implies a modest gain of roughly 12% from recent levels. Support comes from growing AUM, strong fee-revenue momentum, and strategic expansion into credit and wealth channels, while the wide $13-to-$17 analyst range, lumpy performance-fee economics, balance-sheet leverage, and recent target cuts temper the outlook. Whether the stock reaches $15 will depend most on sustained fee growth, fundraising momentum, and how the market re-rates the shares against a 52-week high that sits just below that level. Investors should weigh these factors against their own objectives and risk tolerance rather than treating any single price objective as a certainty.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, GCMG has been loosely correlated with BAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if GCMG jumps, then BAM could also see price increases.
| Ticker / NAME | Correlation To GCMG | 1D Price Change % | ||
|---|---|---|---|---|
| GCMG | 100% | +3.49% | ||
| BAM - GCMG | 61% Loosely correlated | -1.27% | ||
| BX - GCMG | 59% Loosely correlated | -1.23% | ||
| BN - GCMG | 57% Loosely correlated | -1.35% | ||
| ARES - GCMG | 56% Loosely correlated | -0.12% | ||
| KKR - GCMG | 56% Loosely correlated | +2.81% | ||
More | ||||